Compared to placebo, Emblica officinalis fruit extract resulted in lower total cholesterol and LDL-C levels and increased HDL-C levels but with no effect on serum triglyceride levels based on low certainty of evidence. Trials with a larger sample size that directly compare E. officinalis extract to statins, preferably local data, are needed to support its use in patients with dyslipidemia further.
No takes yet. Share an insight, caveat, or question.
Acampado et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: